← Back to Search

Community Health Worker Education for COVID-19

N/A
Waitlist Available
Led By Rakale C Quarells, PhD
Research Sponsored by Morehouse School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have received care for uncontrolled diabetes (HbA1c > 9%) or prediabetes diagnosis within one of the AAPHC 27 community sites
Participants must be between 18 and 50 years
Must not have
Individuals with chronic kidney disease (stage 4-5)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will provide CHWs to homes of vulnerable adults with diabetes & prediabetes to educate about diabetes, COVID-19 & vaccines. The goal is to increase vaccine confidence & uptake, and improve diabetes self-management.

Who is the study for?
This trial is for African American or Latino adults under 50 with uncontrolled diabetes or prediabetes, who have not been vaccinated against COVID-19 (for Phase 1) and are patients within the AAPHC community sites. It excludes those with severe psychological disorders, terminal cancer, chronic kidney disease stages 4-5, pregnant women, and individuals unable to consent.
What is being tested?
The study tests a Community Health Worker intervention in rural areas to boost COVID-19 vaccine confidence and uptake among high-risk groups. It also aims to improve diabetes self-management. Participants will receive home visits for education on diabetes and COVID-19 vaccines.
What are the potential side effects?
Since this trial focuses on educational interventions rather than medical treatments or drugs, there are no direct side effects from medications being tested. However, participants may experience discomfort during health assessments like blood glucose measurement.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have received care for high blood sugar or prediabetes at an AAPHC site.
Select...
I am between 18 and 50 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have advanced chronic kidney disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Blood Glucose Level
Secondary study objectives
Diabetes Self-Management Score
Other study objectives
COVID-19 Vaccination Confidence and Uptake

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CHW InterventionExperimental Treatment1 Intervention
A six week CHW home-visit behavioral intervention examining changes in diabetes outcomes.

Find a Location

Who is running the clinical trial?

Morehouse School of MedicineLead Sponsor
21 Previous Clinical Trials
16,261 Total Patients Enrolled
Rakale C Quarells, PhDPrincipal InvestigatorMorehouse School of Medicine
1 Previous Clinical Trials
82 Total Patients Enrolled

Media Library

CHW Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05863884 — N/A
Coronavirus Research Study Groups: CHW Intervention
Coronavirus Clinical Trial 2023: CHW Intervention Highlights & Side Effects. Trial Name: NCT05863884 — N/A
CHW Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05863884 — N/A
~23 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top